Further work involving hematopoietic-specific Il18−/−/Il18r1−/−/Il18bp−/− mice is now required to better evaluate the intrahepatic contribution of IL-18BP in MASH progression. The gene discussed is IL18; the disease is metabolic dysfunction-associated steatohepatitis.